Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The brains of Alzheimer's disease (AD) patients are morphologically characterized by neurofibrillar abnormalities and by parenchymal and cerebrovascular deposits of β‐amyloid peptides. The generation of β‐amyloid peptides by proteolytical processing of the amyloid precursor protein (APP) requires the enzymatic activity of the β‐site APP cleaving enzyme 1 (BACE1). The expression of this enzyme has been localized to the brain, in particular to neurons, indicating that neurons are the major source of β‐amyloid peptides in brain. Astrocytes, on the contrary, are known to be important for β‐amyloid clearance and degradation, for providing trophic support to neurons, and for forming a protective barrier between β‐amyloid deposits and neurons. However, under certain conditions related to chronic stress, the role of astrocytes may not be beneficial. Here we present evidence demonstrating that astrocytes are an alternative source of BACE1 and therefore may contribute to β‐amyloid plaque formation. While resting astroyctes in brain do not express BACE1 at detectable levels, cultured astrocytes display BACE1 promoter activity and express BACE1 mRNA and enzymatically active BACE1 protein. Additionally, in animal models of chronic gliosis and in brains of AD patients, there is BACE1 expression in reactive astrocytes. This would suggest that the mechanism for astrocyte activation plays a role in the development of AD and that therapeutic strategies that target astrocyte activation in brain may be beneficial for the treatment of AD. Also, there are differences in responses to chronic versus acute stress, suggesting that one consequence of chronic stress is an incremental shift to different phenotypic cellular states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“The major component of senile plaques are b-amyloid peptides, which are derived by proteolytical processing of the amyloid precursor protein (APP; Kang et al. 1987; Tanzi et al. 1987; Weidemann et al. 1989; see Fig.”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 3×
“In the brain, BACE1 is primarily expressed by neurons (Bigl et al. 2000; Roßner et al. 2001), and has been localized to known subcellular structures of b-amyloid generation, i.e. the Golgi apparatus and endosomes (Vassar et al. 1999).”
BackgroundOxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · cited 2×
“Furthermore, a BACE1 EST was identified in a human astrocyte cDNA library, indicating that astrocytes can express BACE1 (Yan et al. 1999).”
BackgroundIdentification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909 · cited 2×
“In particular, astrocytes can degrade b-amyloid deposits in an in vitro system where cultured astrocytes are plated onto spot deposits of b-amyloid peptides or onto mouse brain sections from APP transgenic mice (Wyss-Coray et al. 2003).”
BackgroundOxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · cited 1×
“…2003) and proinflammatory cytokines, such as IL-1b or TGF-b, which are expressed by b-amyloid plaque associated microglial cells in brain of both AD patients (Kalaria 1999; Benveniste et al. 2001) and APP transgenic mice (see e.g. Benzing et al. 1999; Mehlhorn et al. 2000; Apelt and Schliebs 2001).”
BackgroundReview: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity
Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735
Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469
Pro‐regenerative properties of cytokine‐activated astrocytes
Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W., & Levison, S. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02420.x · Cited by 464
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · cited 1×
“IL-1b plays a role in amyloidogenic APP processing in epithelial cells and human astrocytes (Schmitt et al. 1996; Blasko et al. 2000), and TGF-b1 increases APP mRNA expression in vitro (Gray and Patel 1993), and accelerates the deposition of b-amyloid peptides in vivo (Wyss-Coray et al. 1997).”
BackgroundMaturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme
Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M.-Y., & Doms, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004175200 · Cited by 402
The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease
Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369
Uryu, K., Laurer, H., McIntosh, T., Praticò, D., Martinez, D., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00446.2002 · Cited by 337
Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho
Zhou, Y., Su, Y., Li, B., Liu, F., Ryder, J. W., Wu, X., Gonzalez-DeWhitt, P. A., Gelfanova, V., Hale, J. E., May, P. C., et al. (2003) · Science · doi:10.1126/science.1090154 · Cited by 316 · cited 1×
“However, the relative contributions of the distinct intracellular targets of anti-inflammatory drugs – such as cyclooxygenase, the nuclear receptor peroxisome proliferator-activated receptor-c, or Rho – are not established (see Sastre et al. 2003; Yan et al. 2003; Zhou et al. 2003).”
Backgroundβ-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T., & Irizarry, M. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63159-8 · Cited by 294 · cited 1×
“BACE1 mRNA and protein levels are stable during aging of mice and humans (Bigl et al. 2000; Irizarry et al. 2001; Roßner et al. 2001), whereas increased BACE1 enzymatic activity has been reported for several species during aging (Fukumoto et al. 2004).”
BackgroundBlasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223
Wegiel, J., Wang, K. C., Tarnawski, M., & Lach, B. (2000) · Acta Neuropathologica · doi:10.1007/s004010000199 · Cited by 124 · cited 1×
“Additionally, astrocytes have also been shown to be important for b-amyloid clearance and degradation (for review see Wegiel et al. 2000; Guenette 2003; Nicoll and Weller 2003).”
BackgroundNeuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119 · cited 2×
“…a single intrahippocampal lipopolysaccharide (LPS) injection fails to increase the b-amyloid load in APP/presenilin-1 transgenic mice (DiCarlo et al. 2001), but the chronic intracerebroventricular infusion of LPS accelerates b-amyloid deposition in APPV717F transgenic mice (Qiao et al. 2001).”
BackgroundInterferon γ stimulates β-secretase expression and sAPPβ production in astrocytes
Hong, H. S., Hwang, E. M., Sim, H. J., Cho, H.-J., Boo, J. H., Oh, S. S., Kim, S. U., & Mook-Jung, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01270-1 · Cited by 81
A new role for astrocytes: β-amyloid homeostasis and degradation
Nicoll, J. A. R., & Weller, R. O. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00109-6 · Cited by 51
Research works printed but not linked: 70
- Alzheimer A., 1907, Über eine eigenartige Erkrankung der Hirnrinde, Allg. Zeitschr. Psych. Psych.-Gerichtl. Med., 64, 146
- 10.1016/S0169-328X(99)00158-8 · DOI
- 10.1016/S0006-8993(00)03176-0 · DOI · Paper page
- 10.1016/S0304-3940(03)00030-2 · DOI · Paper page
- 10.1016/S0090-3019(96)00461-2 · DOI
- 10.1007/s00210-003-0792-6 · DOI
- 10.1016/S0306-4522(02)00230-0 · DOI
- 10.1002/ana.410380304 · DOI · Paper page
- 10.1016/S0306-4522(99)00390-5 · DOI
- 10.1074/jbc.M005339200 · DOI · Paper page
- 10.1016/S0197-0186(01)00045-6 · DOI · Paper page
- 10.1016/S0197-4580(99)00065-2 · DOI · Paper page
- 10.1523/JNEUROSCI.18-09-03251.1998 · DOI · Paper page
- 10.1016/S0304-3940(00)01452-X · DOI
- 10.1007/s00702-003-0095-6 · DOI · Paper page
- 10.1097/00001756-199709290-00014 · doi:10.1097/00001756-199709290-00014
- BourneK. Lange‐DohnaC. RoßnerS.andPerez‐PoloJ. R.(2004)Rat BACE1 promoter nuclear factor‐κB binding site characterization.Neurobiology of Aging25 supp 2. 141. · doi:10.1016/s0197-4580(04)80474-3
- 10.1016/0891-5849(94)00218-9 · DOI · Paper page
- 10.1038/85064 · DOI · Paper page
- 10.1074/jbc.M003202200 · DOI · Paper page
- 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0 · doi:10.1002/1531-8257(199911)14:6<972::aid-mds1010>3.0.co;2-0
- 10.1161/01.STR.28.5.1073 · DOI · Paper page
- 10.1042/BJ20040682 · DOI · Paper page
- 10.1016/S0892-0362(99)00069-0 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19981201)54:5<635::AID-JNR8>3.0.CO;2-H · DOI · Paper page
- 10.1016/0305-0491(87)90097-6 · DOI
- 10.1073/pnas.93.10.4765 · DOI · Paper page
- 10.1001/archneur.59.9.1381 · DOI · Paper page
- 10.1023/A:1022453332560 · DOI · Paper page
- 10.1016/0169-328X(93)90037-P · DOI
- 10.1002/(SICI)1097-4547(19981001)54:1<7::AID-JNR2>3.0.CO;2-M · DOI
- 10.1089/15230860050192215 · DOI
- 10.1016/S0736-5748(99)00086-6 · DOI
- 10.1016/S1471-4914(03)00112-6 · DOI · Paper page
- 10.1074/jbc.M002095200 · DOI · Paper page
- 10.1002/glia.10178 · DOI · Paper page
- 10.1016/0925-4439(95)00043-4 · DOI
- Hothersall J. S., 1981, Age‐related changes in enzymes of rat brain. Redox system linked to NADH and glutathione, Enzyme, 26, 271, 10.1159/000459190 · doi:10.1159/000459190
- 10.1016/S0002-9440(10)63955-7 · DOI
- 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
- 10.1097/00062752-199901000-00004 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19990201)55:3<357::AID-JNR11>3.0.CO;2-W · doi:10.1002/(sici)1097-4547(19990201)55:3<357::aid-jnr11>3.0.co;2-w
- 10.1093/hmg/6.10.1713 · DOI
- 10.1002/jnr.10639 · DOI · Paper page
- 10.1074/jbc.M300819200 · DOI · Paper page
- 10.1523/JNEUROSCI.20-15-05709.2000 · DOI · Paper page
- 10.1016/S0197-4580(01)00299-8 · DOI · Paper page
- 10.1016/S0306-4522(01)00289-5 · DOI
- 10.1016/S0736-5748(00)00012-5 · DOI · Paper page
- 10.1111/j.1471-4159.1986.tb01745.x · DOI · Paper page
- 10.1016/S0006-8993(00)02869-9 · DOI
- 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
- 10.1523/JNEUROSCI.23-13-05531.2003 · DOI · Paper page
- 10.1046/j.1471-4159.2001.00618.x · DOI · Paper page
- 10.1046/j.1471-4159.1996.67020662.x · DOI · Paper page
- 10.1002/jnr.1095 · DOI · Paper page
- 10.1006/bbrc.1995.2060 · DOI
- 10.1523/JNEUROSCI.23-30-09796.2003 · DOI · Paper page
- 10.1210/jc.81.4.1666 · doi:10.1210/jc.81.4.1666
- 10.1038/990114 · DOI · Paper page
- 10.1016/S0891-5849(98)00131-2 · DOI
- 10.1016/S0891-5849(98)00025-2 · DOI · Paper page
- 10.1016/S0197-4580(02)00023-4 · DOI
- 10.1002/jnr.10428 · doi:10.1002/jnr.10428
- 10.1016/S0891-5849(01)00510-X · DOI
- 10.1111/j.1471-4159.1991.tb02589.x · DOI · Paper page
- 10.1016/0092-8674(89)90177-3 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19980501)52:3<322::AID-JNR8>3.0.CO;2-F · doi:10.1002/(sici)1097-4547(19980501)52:3<322::aid-jnr8>3.0.co;2-f
- 10.1016/0304-3940(95)11919-N · DOI
- 10.1046/j.1471-4159.1996.67062573.x · doi:10.1046/j.1471-4159.1996.67062573.x
Cited by
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
The Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Astrocytes in Alzheimer's Disease
Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C.-Y., & Rodriguez, J. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.017 · Cited by 455
Metadata
- Authors
- Roßner, S., Lange‐Dohna, C., Zeitschel, U., & Perez‐Polo, J. R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-12-09
- Volume
- 92
- Issue
- 2
- Pages
- 226-234
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2049623023
- Cited by
- 163
- References
- 25
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.